An experimental therapy AHA-1031 significantly reduced the size of treatment-resistant lung cancer tumors in animal models by stimulating an immune...

A phase 2 non-randomised clinical trial has demonstrated the potential benefits of pembrolizumab in patients with advanced clear cell gynaecological...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential...

FRIDAY, Feb. 21, 2025 -- Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet...

A new artificial intelligence model has demonstrated high accuracy in detecting and outlining lung tumors on CT scans, according to a study...

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain...

A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively...

Ridgefield, Conn., and Ingelheim, Germany, Feb. 19, 2025 -- Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has...

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects.

A new blood test may help detect pancreatic cancer in its early stages with up to 97% accuracy, according to a recent study. This test looks for...